Page last updated: 2024-12-07
sabinyl acetate
Description
Sabinyl acetate is a naturally occurring monoterpene acetate found in various plants, including the common sage (Salvia officinalis). It exhibits a range of biological activities, including antimicrobial, anti-inflammatory, and antioxidant properties. Research into sabinyl acetate is ongoing due to its potential therapeutic applications, particularly in the development of new drugs for treating bacterial infections and inflammatory diseases. The compound's synthesis can be achieved through various organic chemistry methods, often involving the acetylation of sabinene, another naturally occurring terpene. Further studies are necessary to fully understand its mechanisms of action and potential toxicity before it can be used safely and effectively in clinical settings.'
sabinyl acetate: present in essential oils; RN given refers to cpd without isomeric designation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|
| PubMed CID | 94266 |
| MeSH ID | M0213794 |
Synonyms (13)
| Synonym |
|---|
| bicyclo[3.1.0]hexan-3-ol, 4-methylene-1-(1-methylethyl)-, acetate |
| 4(10)-thujen-3-ol, acetate |
| sabinyl acetate |
| bicyclo(3.1.0)hexan-3-ol, 4-methylene-1-(1-methylethyl)-, acetate |
| 3536-54-7 |
| sabinylacetate |
| PBWRFXQNNGSAQG-UHFFFAOYSA-N |
| 1-isopropyl-4-methylenebicyclo[3.1.0]hex-3-yl acetate # |
| 4-methylidene-1-(propan-2-yl)bicyclo[3.1.0]hexan-3-yl acetate |
| Q67880071 |
| (4-methylidene-1-propan-2-yl-3-bicyclo[3.1.0]hexanyl) acetate |
| DTXSID90956784 |
| AKOS040735016 |
Research
Studies (6)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 22.34
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| Metric | This Compound (vs All) |
|---|
| Research Demand Index | 22.34 (24.57) | | Research Supply Index | 1.95 (2.92) | | Research Growth Index | 4.99 (4.65) | | Search Engine Demand Index | 18.60 (26.88) | | Search Engine Supply Index | 2.00 (0.95) |
| |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 1 (16.67%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (83.33%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |